SEBI Extends IPO Issue Size Revision Relaxation by Up to 50 Percent Till March 2027

In a welcome relief for India Inc. and domestic investment banking circles, the Securities and Exchange Board of India (SEBI) has extended the relaxation allowing companies to revise their initial public offering (IPO) issue size by up to 50% without refiling draft offer documents until March 31, 2027.

The regulatory relief, which was originally introduced for six months and set to expire on September 30, 2026, has been extended through the remainder of the 2026–27 financial year to help issuers adapt to dynamic liquidity conditions and global volatility.

The 50% Rule: What Changed from Standard ICDR Norms

Under standard provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (ICDR Regulations), companies face stringent restrictions once a Draft Red Herring Prospectus (DRHP) is submitted:

• Any upward or downward deviation exceeding 20% in the estimated fresh issue size mandates the withdrawal and fresh filing of the DRHP.
• Refiling offer documents resets regulatory timelines, requiring updated disclosures and re-examination by the regulator, typically delaying an IPO launch by 30 to 75 days.
• For companies that have already secured SEBI observation letters, market corrections or sudden shifts in capital requirements previously meant choosing between letting approvals lapse or proceeding with an unsuitable issue quantum.

Under the relaxed framework, issuers can increase or decrease their fresh issue component by up to 50% on a case-by-case basis, bypassing the need to restart the regulatory cycle from scratch.

Conditions and Regulatory Guardrails

SEBI has maintained strict safeguards to ensure that the procedural ease does not compromise market discipline or investor protection. Companies seeking to adjust issue sizes under this route must comply with key conditions:

Key Regulatory Conditions:

• Unchanged Objectives: The core object of the issue—including the stated utilization of net proceeds—must remain fundamentally unchanged.
• Prior Approval and Justification: Issuers must submit a formal application to SEBI providing commercial justification for the proposed modification.
• Merchant Banker Certification: Book-running lead managers (BRLMs) must certify continued compliance with ICDR disclosure requirements and incorporate all amendments.
• Public Disclosure: All revisions must be made transparent to the public through an official addendum before opening the issue for subscription.

Strategic Timing Amid Market Pressures

The decision follows representations submitted by the Association of Investment Bankers of India (AIBI). Investment bankers highlighted that persistent global macro uncertainties, geopolitical tensions in West Asia, and unpredictable foreign portfolio flows have made it difficult to gauge institutional appetite months in advance.

With dozens of firms holding valid observation letters and a pipeline of planned mainboard share sales exceeding ₹1.5 lakh crore, the extended window prevents a backlog of stalled public offers. It enables promoters and private equity backers to right-size issues according to real-time secondary market liquidity rather than canceling issuances altogether.

What It Means for Indian Investors

For retail and institutional market participants, the extension injects needed flexibility into the capital formation process. Companies are less likely to bring oversized offerings into lukewarm market environments or force overpriced valuations merely to avoid regulatory re-filings. Instead, issuers can downsize to match institutional demand or upsize when market conditions turn favorable, leading to better price discovery and healthier post-listing trading dynamics.

Tags: SEBI Primary Markets IPO Association of Investment Bankers of India BSE NSE